CEimpact Podcast

Curious about the pivotal role pharmacists play in mental health care? Tune into Level Up host Ashlee Klevens-Hayes' enlightening conversation with Amy Werremeyer, a board-certified psychiatric pharmacist, tenured professor & chair of pharmacy practice at North Dakota State University, and tireless advocate for people with mental health and substance use disorders. Hear about her inspiring leap from inpatient psychiatry to her current role in a community mental health center, where she is dedicated to not only prescribing but educating patients about their medications and providing realistic expectations and coping tools.

The second half of our chat dives into the rising demand for specialty pharmacists in the mental health sector and the opportunities that arise with this shift. Amy enlightens us about the potential of improved medication management and non-pharmacological therapies. Her extensive knowledge and passion make her insights on the future of pharmacy in mental health invaluable. From creating access to improving the quality of care, this episode promises to deliver resources, tips, and personal anecdotes that can educate and inspire. Don't miss out on this exploration of mental health in pharmacy with Amy.

To learn more about our Pharmacist by Design membership, click here.

For more info on our upcoming live course 'Illuminating the Darkness: Depression Guideline Update', visit ceimpact.com.

References:
2023 ASHP Forecast
Shatterproof
American Association of Psychiatric Pharmacists

Follow CEimpact on Social Media:
LinkedIn
Instagram

The American Heart Association updated the Coronary Artery Disease (CAD) guidelines for the first time in a decade. Join host, Geoff Wall, as he evaluates what's new in CAD pharmacotherapy.
 
The GameChanger
CAD pharmacotherapy is dependent on aggressive lipid management whereas antiplatelet and beta-blocker therapy is now more nuanced.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Reference
Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023 Jul 20. doi: 10.1161/CIR.0000000000001168. Epub ahead of print. PMID: 37471501.

https://www.ahajournals.org/doi/epdf/10.1161/CIR.0000000000001168

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the new AHA coronary artery disease (CAD) guidelines
2. Apply AHA CAD guidelines for medical management of a patient with stable CAD

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-295-H01-P
Initial release date: 9/4/2023
Expiration date: 9/4/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Episode ten of the Level Up podcast features host Ashlee Klevens Hayes and guest Hashim Zaibak CEO at Hayat Pharmacy. 

Zaibek started Hayat Pharmacy in 2011, a locally owned pharmacy that has since expanded to 20 locations across the greater Milwaukee area. 

In this episode, we discuss pharmacy-based hearing aids and how they can play a role in expanding your services as a pharmacy. Zaibak joins to discuss the benefits Hayat Pharmacy has found as a result of providing OTC hearing aids, the keys to his company's expansion & success, and how pharmacists can swiftly incorporate OTC hearing aids into their own private pharmacy.

To contact Hashim Zaibek, email [email protected]. 

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Narcolepsy can exact a devastating toll on the (probably underdiagnosed) patient. Treatment can range from lifestyle to medications. Join host, Geoff Wall, as he explores a new oral orexin agonist for the treatment of narcolepsy.
 
The GameChanger
Narcolepsy is more common than assumed. Current treatments include stimulant agents but a new class of orexin agonists may be effective, yet have safety concerns.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Dauvilliers Y, Mignot E, Del Río Villegas R, et al. Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1. N Engl J Med. 2023 Jul 27;389(4):309-321. doi: 10.1056/NEJMoa2301940. PMID: 37494485.

https://www.nejm.org/doi/full/10.1056/NEJMoa2301940?query=featured_home

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the manifestations, prevalence, and types of narcolepsy and associated symptoms.
2. Discuss the benefits and risks of orexin drugs in treatment of narcolepsy.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-292-H01-P
Initial release date: 8/28/2023
Expiration date: 8/28/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Episode ten of the Level Up podcast features host Ashlee Klevens Hayes and guest Elizabeth Skoy.  

In this episode, we discuss how your pharmacy can expand its services. Elizabeth joins to discuss her career, and the Center for Collaboration and Advancement in pharmacy.

To learn more about our Pharmacist by Design membership, click here. 

Follow CEimpact on Social Media:
LinkedIn
Instagram

A new biologic agent, Dupilimab, may be a possible treatment for chronic obstructive pulmonary disorder. Join host, Geoff Wall, as he evaluates the use of dupilimab in COPD with Type 2 inflammation
 
The GameChanger
Type 2 inflammation is driven by eosinophils and IL-4, 5, and 11. It occurs in 20% of patients with COPD. Dupilimab was able to decrease COPD exacerbations by 50% and improve symptoms
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. PMID: 37272521.

https://www.nejm.org/doi/full/10.1056/NEJMoa2303951
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the different phenotypes of COPD and treatment options
2. Describe the BOREAS trial and the applicability to patients with COPD

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-288-H01-P
Initial release date: 8/21/2023
Expiration date: 8/21/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The concept of Professional Identity Formation (PIF) is receiving LOTS of attention in pharmacy education recently. What is it and why should it matter to you as a preceptor? Listen to this episode to better understand your critical role in your learners' journey of professional self-discovery.
 
Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Jamie Kellar, BscHK, BScPhm, PharmD, PhD
Associate Dean Academic Organization
Leslie Dan Faculty of Pharmacy
University of Toronto

About Dr. Kellar
Jamie Kellar is an Associate Professor and Associate Dean, Academic at the Leslie Dan Faculty of Pharmacy, University of Toronto.  She received an Honors Bachelor of Science degree in Human Kinetics from the University of Guelph, followed by a Bachelor of Science in Pharmacy and Doctor of Pharmacy degree, both from the University of Toronto.  She obtained her PhD from the School of Health Professions Education, Maastricht University, Netherlands. In addition to her education, she is a licensed pharmacist in Ontario, Canada.  Professor Kellar’s practice area is in the field of mental health. Her research explores professional identity in pharmacy education and practice.  Dr. Kellar is an award-winning educator, having won the University of Toronto Early Career Teaching Award, the President’s Teaching Award, and the Association of Faculties of Pharmacy of Canada (AFPC) National Award for Excellence in Education. Her research on professional identity in pharmacy education also won the Rufus A. Lyman Award for the outstanding paper published in the American Journal of Pharmaceutical Education in 2020.
 
Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
 
Learning Objectives
At the end of this course, preceptors will be able to:
1. Discuss the importance of professional identity formation (PIF) in student pharmacists and pharmacy residents
2. Describe strategies to mentor and support pharmacy learners in PIF

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-318-H99-P
Initial release date: 8/16/2023
Expiration date: 8/12/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Episode nine of the Level Up podcast features host Ashlee Klevens Hayes and guest pharmacist Rikki Horne.  

In this episode, we discuss how veterinary medicine can play a role in your pharmacy. Rikki joins to discuss her professional experiences & expertise as a pharmacist specialized in veterinary medicine. 
 
To learn more about our advanced trainings in veterinary medicine for pharmacists & technicians, click here.

To learn more about our Pharmacist by Design membership, click here. 

Follow CEimpact on Social Media:
LinkedIn
Instagram

The pharmacotherapy for tobacco cessation continues to evolve with new treatment options. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss the role of the pharmacy team in tobacco cessation.
 
The GameChanger
Pharmacotherapy alone may not be sufficient for tobacco cessation - counseling and support are often required. A new medication, cytisinicline, may provide additional options for treatment.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad
 
Reference
Rigotti NA, Benowitz NL, Prochaska J, et al. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA. 2023 Jul 11;330(2):152-160. doi: 10.1001/jama.2023.10042. PMID: 37432430; PMCID: PMC10336611.

https://jamanetwork.com/journals/jama/article-abstract/2807079
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss obstacles to effective tobacco cessation therapy
2. Compare and contrast cytisinicline with other pharmacotherapy agents for tobacco cessation

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-287-H01-P
Initial release date: 8/14/2023
Expiration date: 8/14/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Episode eight of the Level Up podcast features host Ashlee Klevens Hayes and guest Jake Galdo.  

In this episode, we discuss Community Health Workers (CHW) and their role in the community. Jake joins to cover the benefits of becoming a CHW and the necessities to addressing health inequity within your community. 
 
To read more about CHW's, read this article mentioned in the beginning of the episode. 

To learn more about CEimpact's CHW training, click here.  

To learn more about our Pharmacist by Design membership, click here. 

Contact us via [email protected] to get started today. 

Follow CEimpact on Social Media:
LinkedIn
Instagram